Maastricht University Medical Center
Maastricht, Netherlands
NCT Number: NCT02510482
Calcified aortic valve stenosis (CAVS) is a progressive disease and nowadays, the cornerstone in diagnostics and follow-up is echocardiography. Cardiac biomarkers (such as cardiac troponins T and I and NT-pro-BNP) hold promise to fulfil a role in early recognition of complications concerning the aortic valve and decompensation. For this purpose, it is important to assess the normal biological variation (BV) of cardiac biomarkers in CAVS. The assessment of biological variation will contribute to a better understanding of fluctuation of cardiac biomarkers in subjects with stable CAVS. These data will improve monitoring of CAVS using cardiac biomarkers.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Maastricht, Netherlands
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: One year
Time frame: One year
Time frame: One year
Maastricht University Medical Center
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02729519
Aortic Valve Disease, Aortic Valve Stenosis
Montpellier, France
View Trial DetailsNCT07605780
Aortic Valve Disease, Aortic Valve Stenosis
Brescia, BS, Italy
View Trial DetailsNCT06171802
Aortic Valve Disease, Aortic Valve Stenosis
Copenhagen, Denmark
View Trial DetailsNCT05774691
Aortic Valve Disease, Aortic Valve Stenosis
Aalst, Belgium
View Trial Details